Net Income

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

A new national ranking moves beyond funding and publications to reveal which U.S. research institutions are truly effective at creating real-world cures.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

The U.S. Highbush Blueberry Council is betting on startups to find new uses for blueberries in everything from skincare to pet food. Here's what's next.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

With huge energy needs, Israel's water company Mekorot turns to nT-Tao's fusion tech in a bold move that could redefine national infrastructure resilience.

As AI and usage-based pricing complicate finance, BillingPlatform launches RevVenue, an expert-led hub to help firms navigate a new era of compliance risk.

The trading signal provider is rolling out new automated tools, touting major Q1 gains. But how do its claims stack up in a competitive, skeptical market?

With staggering 34% revenue growth, United Imaging is leveraging R&D and global expansion to disrupt the Western-dominated medical imaging market.

KCIC's 2025 report shows asbestos filings hitting a new peak, driven by a dramatic rise in talc-related lawsuits and massive jury awards.

The Emmy-nominated documentary 'Bribe, Inc.' uncovers the massive Unaoil scandal, highlighting the risky work of journalists and the role of film.

A new campaign aims to save a major research hub, igniting a debate over its economic benefits, medical breakthroughs, and the future of animal testing.

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.

Ardmore Shipping orders advanced tankers and doubles its dividend, capitalizing on soaring charter rates while signaling long-term confidence in the market.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

A first-in-class drug, NTX-2001, is now in human trials for alcohol use disorder, offering a new mechanism of action in a field with few options.

The Hawaii-based bank posted $20.7M in Q1 earnings, balancing shareholder returns with a deep-rooted commitment to local business growth.

Fintech giant OppFi acquires BNC National Bank, a transformative move to become a bank holding company and reshape financial access for underserved Americans.

As unmonitored AI use on smartphones exposes corporate data, Lookout's new platform aims to bring hidden mobile AI activity out of the shadows.